We have compared the delay in onset of 1% mepivacaine and 0.33% bupivacaine in different nerve fibre types in 10 volunteers undergoing median nerve blocks, in a randomized, double-blind, crossover study. Hot, cold, pinprick and light touch sensations, compound motor action potentials (CMAP), sensory nerve action potentials (SNAP) and skin temperature were recorded at 2-min intervals. Hot, cold, pinprick, light touch sensations, SNAP and CMAP were significantly inhibited, and skin temperature was significantly increased after administration of both agents. The first noticeable reduction in cold sensation was detected later after bupivacaine compared with mepivacaine, but after a delay similar to that of other nerve functions. Bupivacaine and mepivacaine inhibited SNAP and CMAP with a similar time delay to steady-state. Bupivacaine produced steady-state inhibition of hot and cold sensations significantly later than mepivacaine; nevertheless, the sequence that sensory modalities failed, with few exceptions, and the extent of anaesthesia at 40 min were similar for both agents. Our technique provides a novel, multi-modal method of comparing local anaesthetics and related agents over time. (Br. J. Anaesth. 1998; 81: 515-521) Keywords: nerve, differential block; nerve, transmission; anaesthetics local, bupivacaine; anaesthetics local, mepivacaine; anaesthetic techniques, regional
In clinical practice, bupivacaine appears to have a slower onset of action than mepivacaine, but bupivacaine is thought to inhibit sensory nerve fibres more selectively than mepivacaine. 1 We hypothesized that these differences in nerve blocking characteristics of bupivacaine and mepivacaine could be measured during onset of block with local anaesthetic solutions used in clinical practice, even though these solutions would be expected to produce similar anaesthetic conditions at steady-state. We tested this hypothesis using median nerve blocks as a model system for clinical regional anaesthesia. We chose to study clinical drug concentrations, greatly reducing the possibility that we would detect steady-state differences between sensory modalities or between sensory nerve inhibition, motor nerve inhibition and skin temperature, such as might be observed with lesser degrees of nerve inhibition. That is we did not design our experiment to produce differential block at steady-state and we anticipated inhibition of all modalities.
We assessed speed of onset of inhibition (over 40 min) of median nerve fibre transmission using both objective and subjective data, as in previous studies. 2 3 We obtained objective data (compound motor action potentials (CMAP), sensory nerve action potentials (SNAP) and skin temperature) using standard electrodiagnostic techniques which are particularly useful for comparing inhibition of large myelinated motor and sensory nerve fibres. As SNAP (and CMAP) are composed of summated signals from thousands of axons, specific alteration of one sensory modality could conceivably occur without measurable decrement in SNAP amplitude. In particular, sensory modalities mediated by smaller myelinated or unmyelinated nerve fibres can be inhibited without alteration in SNAP, which measure predominately large (A␣) fibre activity. 4 Therefore, we also used somesthetic testing, the most practical means by which to measure local anaesthetic effects on specific sensory modalities in humans. We assessed subjective perception of cold, hot and pinprick by comparing the same stimulus applied to anaesthetized and unanaesthetized skin, and documenting the persistence of sensation after anaesthesia as a percentage of sensation in unanaesthetized skin. The validity of this "self-reporting" technique has been documented previously. 5 6 Light-touch sensibility was quantitated in anaesthetized skin with von Frey hairs, which yield an explicit measurement of the threshold force stimulus for perception of light touch. 32 (range 22-38) yr. Median nerves in dominant and non-dominant hands were studied in either order. Only one drug was injected at each wrist; the two drugs were never studied simultaneously. Bupivacaine and mepivacaine were injected in a random, blinded, crossover manner. The first drug to be studied was selected by the flip of a coin. The first wrist to be injected was selected based on the direction in which the volunteer lay on the examination table. Seven specific assessments were performed before and after injection of mepivacaine or bupivacaine.
Objective measurements included CMAP, SNAP, light touch sensibility and skin temperature. A Nicolet (Madison, WI) Viking electrodiagnostic instrument was used to assess A␣ sensory and motor fibres using orthodromic CMAP and antidromic SNAP. 8 Supramaximal (more than 150% of the stimulus which produced maximal SNAP and CMAP amplitudes) electrical stimulation of the median nerve 2 cm proximal to the site of injection of local anaesthetic simultaneously elicited CMAP and SNAP. Belly tendon surface electrodes recorded CMAP from the abductor pollicis brevis muscle; ring electrodes at the base and distal end of the middle finger recorded SNAP. Amplitudes (measured from baseline to peak of the signal) of CMAP and SNAP are reported as percentage of baseline values measured before injection of local anaesthetic. Unmyelinated C-fibre function was monitored measuring skin temperature at the distal end of the index figer with a thermistor accurate to 0.1ЊC.
Subjective measurements included self-reporting of the perceived intensity of standard hot, cold and pinprick stimuli. Light touch, pinprick, and hot and cold sensations were tested on the proximal palmar surface of the third digit and compared with the same stimulus applied on the volar aspect of the ipsilateral forearm, halfway between the wrist and elbow. These two test sites were marked so that constant regions of skin were tested. Light touch sensibility was assessed using von Frey hair monofilaments (Stoelting Inc., Evanston, IL, USA), which deliver no more than a defined force before bending. 2 7 We confirmed that our von Frey hairs were approximately calibrated by measuring the force required to bend the monofilaments on a laboratory balance. Pinprick sensation was tested using an opened 2-cm safety pin with its point into the skin just sufficiently to cause visible indentation. Hot and cold sensations were assessed using a 1 1 cm aluminum bar either cooled to a constant temperature of 5-7ЊC or heated to a constant temperature of 49-52ЊC. Temperatures were maintained by water baths and remained constant during each experiment. Hot and cold sensations were recorded as a percentage of the sensation perceived in unanaesthetized forearm skin.
After baseline data for all modalities were recorded, the wrist was cleansed with isopropyl alcohol. Median nerve block was performed by inserting a 22-gauge needle just lateral to the palmaris longus tendon and through the flexor retinaculum. We performed our median nerve blocks without using an electrical nerve stimulator and we deliberately avoided producing paraesthesia. Thus it could be argued that we injected our local anaesthetic solutions at an unknown and variable distance from the median nerve. Nevertheless, our technique has produced consistent, successful anaesthesia in this and previous studies. 2 3 5 Bupivacaine 0.33% or 1% mepivacaine 5 ml (both from Astra Pharmaceuticals, Westborough, MA, USA) were injected over 30-45 s. The bupivacaine solutions were formulated by diluting 0.5% bupivacaine with sterile 0.9% saline (Abbott Laboratories, Chicago, IL, USA). These concentrations were judged to be equally efficacious based on widespread clinical use and on unpublished pilot studies in amphibian peripheral nerve. 9 10 Equal efficacy was sought, as speed of onset is greater with more concentrated local anaesthetic solutions. Thus onset of anaesthesia is faster after injections of a solution which yield complete anaesthesia at steady-state compared with a less concentrated solution. A meaningful comparison between two compounds would require that they are presented in concentrations which would yield a similar extent of block at steadystate (equivalent efficacy). All assessments were performed every 2 min over 40 min.
In a power analysis before collecting our data, we assumed that there would be a mean difference of 10 min between bupivacaine and mepivacaine in the time delay until steady-state effects after hot, cold and pinprick sensations were achieved. We assumed an SD of 10 min, ␤:0.90 and ␣:0.05. Using paired data to test (one-sided) if mepivacaine was faster than bupivacaine, we estimated that nine volunteers would be needed.
Data are presented as median (confidence intervals). Non-parametric statistical tests were used throughout as our subjects often became insensible to light touch (with von Frey hairs), even with our maximal stimulus, and parametric tests cannot function with "infinite" values. Although many of our assessment techniques produced data that did not deviate significantly from a Gaussian distribution, data from other assessment techniques were clearly not normally distributed. For consistency, we elected not to use parametric techniques for some and nonparametric for others. The presence of a monotonic drug effect over time was indicated when significant Spearman's rank correlations were found between change in measurement and experimental time (measured from the time of drug injection). Data were compared between drugs using four measures: (1) time delay from drug injection until measurement declined or increased to within 10% of the steady-state measurement (values recorded 40 min after injection of local anaesthetic were assumed to be steady-state measurements as nearly every measurement had reached its nadir or zenith well before this time); (2) time delay after drug injection until the first noticeable differences were recorded (only for sensory modalities where subjective responses were recorded); (3) drug effect measured at 40 min; and (4) median drug effect during the course of the experiment using the area under the drug effect vs time curve. The latter comparison is analogous to a repeated measures analysis of variance, but for nonparametric data. Using this technique, anaesthetics which produced greater inhibition of hot, cold, pinprick, SNAP or CMAP had less area under the effect vs time curve; anaesthetics which produced greater inhibition of light touch had greater area under the effect vs time curve. Changes in skin temperature were not assessed using this technique as skin temperature usually declined before increasing (as discussed above), making any calculation of effect-time area uninterpretable.
Electrophysiological data were reported as percentage of baseline amplitude. Light touch was reported as absolute threshold (measured in mN). Paired Fisher's sign test was used to compare drug effects, using one-sided tests for onset differences between drugs (testing our hypothesis that mepivacaine was faster) and two-sided tests for comparing steady-state drug effects (as our null hypothesis was that the two drug concentrations were equipotent at steady-state). Paired Fisher's sign test was also used to compare the two local anaesthetics at steady-state, using sensory failure (inability to sense hot, cold, pinprick or light touch) as our test criterion. No corrections were made to P values; however, to account for multiple comparisons, we arbitrarily assigned P:0.025 as our threshold for statistical significance.
Results
Data were collected after injection of both bupivacaine and mepivacaine in all 10 volunteers. In the study population as a whole, median perceived intensity of cold, hot and pinprick sensations declined significantly (P:0.001) over time after both bupivacaine and mepivacaine ( fig. 1) . Each volunteer showed significant declines in cold, hot and pinprick sensations except for one individual (P:0.10 after mepivacaine but P:0.02 after bupivacaine for hot sensation). Repeated presentation of the same stimulus could lead to accommodation and a decrease in perceived intensity. Nevertheless, our subjects identified no consistent alteration in stimulus intensity in unanaesthetized skin. Bupivacaine and mepivacaine significantly increased the threshold stimulus for perception of light touch, both overall (P:0.001 for all subjects together) and for each subject individually ( fig. 2 ). SNAP and CMAP declined significantly (P:0.001) after bupivacaine and mepivacaine, both for all subjects and for each volunteer individually ( fig. 3 ).
Both drugs significantly increased skin temperature (P:0.001). Skin temperature usually declined immediately, but only briefly, after local anaesthetic injection ( fig. 4) .
During onset of anaesthesia, there was no significant difference between the two agents in the time delay until a first noticeable decline in pinprick, hot and light touch sensations was detected by our volunteers (table 1) . In contrast, a change in cold sensation was detected a median 2 min later after bupivacaine than after mepivacaine, and this difference was statistically significant (P:0.008).
The two drugs achieved maximal inhibition of light touch sensation after similar time delays following injection (table 2, fig. 2 ). In contrast with the other modalities, skin temperature had not Figure 2 Effects of mepivacaine and bupivacaine on threshold for light-touch sensation assessed using von Frey hairs. The threshold increased significantly after both agents. After mepivacaine, five of 10 subjects had complete loss of light-touch sensation, whereas none of 10 subjects lost light-touch sensation after bupivacaine (P:0.01, Fisher's exact test). Data are reported as median threshold for light touch. Mepivacaine depressed CMAP marginally faster than bupivacaine. At steady-state, inhibition was similar after the two agents. There were no significant differences between the agents in inhibition of SNAP. All data are presented as median values. Figure 1 Effects of mepivacaine and bupivacaine on perception of pinprick, hot and cold. Subjects described the intensity of stimuli in anaesthetized skin as a percentage of perceived intensity in a constant region of unanaesthetized skin. Initially, perceived intensity was the same at the two sites, which was recorded as 100%. Bupivacaine had a significantly slower onset of inhibition for hot, pinprick and cold sensibility than mepivacaine. All data are reported as medians. always reached its zenith by the 40-min measurement ( fig. 4) after injection of either mepivacaine or bupivacaine. Steady-state inhibition of hot and cold sensation was observed significantly later after bupivacaine than after mepivacaine (table 2, fig. 1 ).
The rate and extent of inhibition by bupivacaine and mepivacaine were also evaluated by comparing the area under the effect vs time curve (table 3) . Pinprick, cold and light touch sensations showed significantly less inhibition after bupivacaine compared with mepivacaine.
Drug effects measured at 40 min were also compared. In general, there were no significant differences between the agents at 40 min (steady-state). After bupivacaine, the threshold approached the maximal value for light touch in only one volunteer (von Frey hair technique), and no subject lost the ability to sense light touch. After mepivacaine, the threshold for light touch sensation increased above the maximal value (von Frey hair technique) in five of 10 volunteers (P:0.01, Fisher's exact test). Nevertheless, median steady state light touch thresholds were not significantly different between the two local anaesthetics (fig. 2) .
The rate and extent of inhibition of the various sensory modalities and electrodiagnostic tests produced by bupivacaine and mepivacaine were also compared using the area under the effect vs time curve (table 4) . Using this technique, pinprick sensation was inhibited significantly less than hot sensation after bupivacaine and mepivacaine. Hot sensation was inhibited to a significantly greater extent than SNAP and CMAP after both agents, and to a greater extent than cold after bupivacaine. Cold sensation was inhibited to a significantly greater extent than SNAP and CMAP after mepivacaine but not after bupivacaine. No other comparisons approached statistical significance. We did not compare light touch sensation or skin temperature with other modalities because our measurements of the former (in contrast with the other modalities) increased over time. Measurements of the latter were not monotonic and also demonstrated increased values at the 40-min measurement relative to starting measurements. Figure 4 Effects of mepivacaine and bupivacaine on skin temperature. Data are presented as absolute temperature change (ЊC) compared with baseline measurements. Differences between bupivacaine and mepivacaine were not significant. Consistent with our experience with lidocaine, most subjects demonstrated an initial decline in skin temperature, presumably from a sympathetic response to pain on injection, before demonstrating an increase in skin temperature as a result of presumed C-fibre (or preganglionic B fibre) inhibition and vasodilatation. Data are reported as median values. Table 1 Comparison of mepivacaine with bupivacaine on median latency of first noticeable difference in sensation. All data are presented as median time delay. P values were calculated for one-way Fisher's sign test (to test if mepivacaine produced a "just noticeable"difference sooner than bupivacaine). Differences were calculated using paired data from each subject, subtracting the time delay after mepivacaine from the time delay after bupivacaine 
Discussion
Our data have demonstrated that during onset of median nerve block, 0.33% bupivacaine inhibited sensations of cold and hot significantly more slowly compared with 1% mepivacaine. A "just noticeable" difference in cold sensation was detected significantly later with bupivacaine than with mepivacaine. In contrast, at the 40-min assessment, there were no significant differences between the agents for inhibition of SNAP and CMAP. While mepivacaine generally has a faster onset of median nerve block than bupivacaine, the various sensory modalities and nerve fibre types responded in different ways. Some measurements consistently had greater overall inhibition than others. Hot sensation was inhibited to a greater overall extent than pinprick sensation, SNAP or CMAP, consistent with a faster onset (table 4) . Thus the clinician can expect to receive earlier signs of nascent median block from either bupivacaine or mepivacaine by testing with a hot stimulus than by using pinprick. Curiously, hot sensation was inhibited significantly faster than cold sensation after bupivacaine but not after mepivacaine. The relatively faster onset of inhibition of cold sensation after mepivacaine (compared with bupivacaine) resulted in significant differences in onset between cold and SNAP and CMAP with mepivacaine, but not with bupivacaine. In contrast, the clinician is less likely to be surprised by incomplete anaesthesia if loss of pinprick sensation or the signals from electrodiagnostic tests (SNAP and CMAP) are used as criteria for satisfactory anaesthesia, rather than a thermal stimulus. We also noted that our techniques provided a novel means by which responses to local anaesthetics and other peripheral-acting analgesic agents may be compared over time. Whereas differential block of nerve fibres in vitro has been shown to occur (using electrophysiological measurements) with constant (submaximal) concentrations of local anaesthetics (at steady-state), we found limited evidence for differential block after 40 min of exposure to clinical drug concentrations (when local anaesthetic binding to Na channels should have reached a maximum). 11 12 Indeed, as expected, we identified few differences between bupivacaine and mepivacaine at 40 min. Bupivacaine 0.33% and 1% mepivacaine produced profound inhibition after 40 min.
Our technique, which included testing of multiple sensory modalities, action potentials from sensory and motor systems, and skin temperature, allowed detection of subtle differences in the extent of conduction block of different fibres. Nevertheless, it has many limitations. We did not objectively measure intra-subject variability, that is the consistency with which each volunteer graded onset of block. Such comparisons have been performed previously. 6 We have previously documented measurements after median nerve block with 0.9% saline, confirming the Table 4 Comparisons of median overall drug effects measured as area under the effect vs time curves (% min). SNAP:Sensory nerve action potentials; CMAP:compound motor action potentials. All data are presented as medians (first modality-second modality) in units of % min. Statistical comparisons were performed using paired data from each subject. A positive value indicates that the first modality was inhibited less than the second modality over the course of the experiment ability of volunteers to detect no significant alteration in the perceived intensity of constant sensory stimuli. 5 Sensory thresholds may vary dramatically over small regions of skin. 13 To overcome this potential variability, we marked the skin and presented the stimuli to the same location each time.
We recognize that in many cases we have not measured the time of sensory or motor nerve failure, but measured decrements in nerve fibre function over time. Thus our conclusions regarding onset (where we used the time delay until steady-state conditions were obtained) may differ from those of other authors who may have taken onset of local anaesthesia as complete insensibility. We also recognize that each peripheral nerve may have its own organizational characteristics, and may carry different fibre types. Thus we cannot exclude the possibility that different results may have been obtained had we tested mepivacaine and bupivacaine on a different peripheral nerve. Such comparisons are planned.
We recognize that some measurements, notably skin temperature, may not have reached steady-state values by 40 min. In these cases, estimates of median time delay to achieve steady-state drug effects must be interpreted cautiously. We found a similar onset of increase in skin temperature after mepivacaine and bupivacaine, possibly because bupivacaine has a predilection for inhibiting unmyelinated vasomotor C fibres (or preganglionic B fibres), as onset of bupivacaine anaesthesia was slower for most other modalities. Alternatively, delay between sympathetic nerve block and an increase in skin temperature could obscure differences between mepivacaine and bupivacaine. Data recording longer than 40 min may be required to detect a difference between these agents. Finally, skin temperature usually declined immediately, but only briefly, after injection of local anaesthetic, probably as a result of pain-and anxiety-induced peripheral vasoconstriction, making assessment of onset times for an increase in skin temperature more difficult to define.
We believe that mepivacaine and bupivacaine concentrations used in this study were nearly equipotent for clinical nerve blocks and our results at 40 min support that belief. Most studies comparing the clinical effects of mepivacaine and bupivacaine have found relative potency ratios (using drug concentrations measured in mg dl 91 ) of 1:3-1:4. 9 14-16 Similar molar potency ratios have been observed in studies of local anaesthetics applied to isolated nerves. 10 Thus using these data as our guide, as a worst case, the mepivacaine solution used in this study should have been equivalent or slightly less potent than the bupivacaine solution. Careful comparison of sub-blocking concentrations of the various local anaesthetics using our measurement techniques could yield accurate and precise concentration equivalency data in humans, data which are at present lacking. We recognize that speed of onset of local anaesthesia is related to the dose of local anaesthetic and that miscalculation of the relative potency of mepivacaine and bupivacaine could confound comparison between them regarding relative rates of onset.
Our data suggest that a decline in perceived intensity of heat is the earliest subjective test identifying onset of median nerve block. Other studies have found that temperature sensation is impaired early during nerve blocks (for review, see Raymond and Gissen 1 ). We also found that the nerve fibres subserving sensations of hot and cold (A-Ѩ and C-fibres) were inhibited more rapidly by local anaesthetics than fibres responsible for pinprick sensation (AѨ fibres). 1 These findings are at variance with the in vitro work of Gissen and colleagues, who found that C fibres were more resistant to local anaesthesia than A␣ fibres. 11 12 14 Gissen and colleagues performed their studies at steady-state in isolated rabbit vagus nerves; thus differences between their data and ours could result from species differences or from differences in the internal architecture between cranial (vagus) and peripheral (median) nerves. Differential onset of anaesthesia could have different underlying mechanisms than differential block at steady-state.
A decline in hot or cold sensation may not provide a reliable test for adequacy (completeness) of neural block for surgical incision. Although surgical anaesthesia can be obtained without complete motor block, the presence of motor block substantially increases the likelihood that adequate sensory anaesthesia is also present after either local anaesthetic, as loss of CMAP amplitude did not precede loss of sensory modality. Clinicians generally do not have the capability of monitoring CMAP, and we caution that other tests of motor block may not yield identical results.
We conclude that 1% mepivacaine generally produced more rapid onset of anaesthesia than 0.33% bupivacaine. Of potential clinical importance was that thermal sensation appeared more susceptible to block than other modalities after both agents. Testing for small fibre block using a warm stimulus may provide an overly sanguine assessment of inhibition of larger sensory and motor nerve fibres, particularly during onset of anaesthesia. Therefore, we advise caution if clinicians choose tests of small fibre function (hot or cold sensation) to determine if regional block is adequate for surgical incision. Further study is required to determine if the characteristics of median block which we observed can be extrapolated to other local anaesthetics, other nerves, or spinal or epidural anaesthesia. But we predict that our measurement techniques may prove useful to define precisely differences between local anaesthetics with regard to potency and differential block of sensory modalities during clinical regional anaesthesia. Our technique is particularly useful as longerpersisting agents which produce selective analgesia become available for treatment of acute and chronic pain.
